| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.0M | +18.1% |
| SG&A Expense | $1.1M | +1104.9% |
| Operating Income | -$4.4M | -2349.8% |
| Pre-tax Income | -$3.6M | -1896.0% |
| Net Income | -$3.6M | -1896.0% |
| EPS (Basic) | -$0.01 | — |
| EPS (Diluted) | -$0.01 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | +5978.0% |
| Current Assets | $3.5M | +5628.9% |
| Total Assets | $3.5M | +5632.8% |
| Current Liabilities | $297K | -62.1% |
| Total Liabilities | $302K | -61.4% |
| Stockholders' Equity | $3.2M | +536.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | -1705.4% |
| Investing Cash Flow | $18K | — |
| Financing Cash Flow | $4.7M | — |